Catalog No Product Name Applications
EVV25601 Recombinant Norovirus GII VP1/ORF2 Protein, C-His ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
RVV25604 Anti-Norovirus/Norwalk virus Capsid protein/VP1 Nanobody (Nano-85) ELISA
RVV25605 Anti-Norovirus/Norwalk virus Capsid protein VP1/p59 Antibody (5I2) ELISA, SPR
RVV25606 Anti-Norovirus/Norwalk virus Capsid protein VP1/p59 Antibody (Nano-7) ELISA
RVV25607 Anti-Norovirus/Norwalk virus Major capsid protein/VP1 Antibody (A1431) ELISA, Neutralization
RVV33401 Anti-Mouse Norovirus Capsid protein Antibody (A6.2) ELISA, Neutralization
RVV25601 Anti-Norovirus/Norwalk virus Capsid protein Antibody (5B18) ELISA, WB
RVV25602 Anti-Norovirus/Norwalk virus Capsid protein/VP1 Antibody (Nano-4) ELISA
RVV25603 Anti-Norovirus/Norwalk virus Capsid protein/VP1 Antibody (Nano-25) ELISA
RVV25608 Anti-Norovirus/Norwalk virus Major capsid protein/VP1 Antibody (A1227) ELISA, Neutralization

 

参考文献:

[1]Carlson, Katherine B et al. “A narrative review of norovirus epidemiology, biology, and challenges to vaccine development.” NPJ vaccines vol. 9,1 94. 29 May. 2024, doi:10.1038/s41541-024-00884-2

文章推荐
XML 地图